Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features. (Q41563600)
Jump to navigation
Jump to search
scientific article published on 25 October 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features. |
scientific article published on 25 October 2016 |
Statements
Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features (English)
Paulina A García-González
Katina Schinnerling
Alejandro Sepúlveda-Gutiérrez
Jaxaira Maggi
Lorena Hoyos
Ahmed M Mehdi
Hendrik J Nel
Lilian Soto
Bárbara Pesce
María Carmen Molina
Miguel Cuchacovich
Milton L Larrondo
Óscar Neira
Diego Francisco Catalán
Ricardo A Verdugo
Juan C Aguillón
25 October 2016
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference